Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:7587 |
Name | supraglottis squamous cell carcinoma |
Definition | |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer organ system cancer respiratory system cancer larynx cancer supraglottis cancer carcinoma of supraglottis supraglottis squamous cell carcinoma |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04892173 | Phase III | Cetuximab NBTXR3 | NBTXR3 With or Without Cetuximab in LA-HNSCC | Recruiting | USA | SWE | ROU | ISR | HUN | HRV | GRC | GBR | FRA | FIN | ESP | DEU | CZE | CAN | BRA | BGR | BEL | AUT | 9 |
NCT05376553 | Phase I | Cemiplimab + Cisplatin + Docetaxel | Study of Cemiplimab - TP Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Recruiting | USA | 0 |
NCT05433116 | Phase II | Lenvatinib + Pembrolizumab | Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC | Recruiting | DEU | 0 |